The CMS List of Selected Drugs: Developing Effective Arguments for Pricing of Selected Drugs Under the Inflation Reduction Act of 2022 | BakerHostetler

On Aug. 29, the Centers for Medicare & Medicaid Services (“CMS”) issued the inaugural list of drugs selected for price setting under the Inflation Reduction Act of 2022 (IRA). Those...

Related Keywords

United States ,Meena Seshamani ,Medicare Drug Price Negotiation Program ,Supreme Court ,Centers For Medicare Medicaid Services ,Bakerhostetler Drug Pricing Team ,Human Services ,Medicaid Services ,Drug Pricing Team ,Department Of Health ,Inflation Reduction Act ,Reduction Act ,Revised Guidance ,Social Security Act ,Initial Price Applicability Year ,